South Korea Active Pharmaceutical Ingredients Market is Segmented By Product Type (Low Potent APIs, High Potent APIs), By Molecular Type (Small Molecules, Large Molecules), By Formulation (Oral, Topical, Injectables, Drops), By Application (Diabetes, Oncology, Cardiovascular, CNS, Analgesics, Ophthalmic, Respiratory, Dermatology, Others). The report offers the value (in USD Billion) for the above-mentioned segments
Market Size in USD
CAGR5.1%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 5.1% |
Market Concentration | Medium |
Major Players | Teva Pharmaceutical Industries Ltd., Kyongbo Pharm, SAMOH Pharm. Co., Ltd. , SHINPOONG.CO,.LTD, Kukjeon Pharmaceutical Co., Ltd. |
The South Korea Active Pharmaceutical Ingredients Market is estimated to be valued at USD 6.1 Bn in 2024 and is expected to reach USD 7.9 Bn by 2031, growing at a CAGR of 5.1% from 2024 to 2031.
The market growth is driven by the increasing prevalence of chronic diseases and rising geriatric population in the country.